Past PSI Events

Conferences

PSI Webinar - Main statistical approaches for quantitative decision-making in drug development

Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:

speakers

  • Pierre Colin (Sanofi)
  • Juan Abellan (GSK)
  • Gaëlle Saint-Hilary (Servier)

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

Registration: To register for this free webinar, please click here.

Please email PSI@mci-group.com if you have any questions.

Scientific Meetings

PSI Webinar - Main statistical approaches for quantitative decision-making in drug development

Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:

speakers

  • Pierre Colin (Sanofi)
  • Juan Abellan (GSK)
  • Gaëlle Saint-Hilary (Servier)

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

Registration: To register for this free webinar, please click here.

Please email PSI@mci-group.com if you have any questions.

Training Courses

PSI Webinar - Main statistical approaches for quantitative decision-making in drug development

Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:

speakers

  • Pierre Colin (Sanofi)
  • Juan Abellan (GSK)
  • Gaëlle Saint-Hilary (Servier)

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

Registration: To register for this free webinar, please click here.

Please email PSI@mci-group.com if you have any questions.

Journal Club

PSI Webinar - Main statistical approaches for quantitative decision-making in drug development

Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:

speakers

  • Pierre Colin (Sanofi)
  • Juan Abellan (GSK)
  • Gaëlle Saint-Hilary (Servier)

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

Registration: To register for this free webinar, please click here.

Please email PSI@mci-group.com if you have any questions.

Webinars

PSI Webinar - Main statistical approaches for quantitative decision-making in drug development

Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:

speakers

  • Pierre Colin (Sanofi)
  • Juan Abellan (GSK)
  • Gaëlle Saint-Hilary (Servier)

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

Registration: To register for this free webinar, please click here.

Please email PSI@mci-group.com if you have any questions.

Careers Meetings

PSI Webinar - Main statistical approaches for quantitative decision-making in drug development

Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:

speakers

  • Pierre Colin (Sanofi)
  • Juan Abellan (GSK)
  • Gaëlle Saint-Hilary (Servier)

Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.

Registration: To register for this free webinar, please click here.

Please email PSI@mci-group.com if you have any questions.

Upcoming Events

PSI Book Club - The Art of Explanation: How to Communicate with Clarity and Confidence

Develop your non-technical skills by reading The Art of Explanation by Ros Atkins and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply skills from the book in-between sessions.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

AIMS SIG - Open-Source Lunch Bites

Topic: R Package Basics. Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “R Package Basics,” will introduce the fundamentals of working with R packages—covering how to install, load, and manage them effectively to support data analysis and reproducible research. The session will provide a solid starting point, clarify common misconceptions, and offer valuable resources for continued learning.

PSI Journal Club: Missing Data

Date: Thursday 13th November 2025 Join us to hear Cesar Torres and Suzie Cro present their recent work.

Pre-Clinical SIG Webinar: Modern Algorithms for Animal Randomization in Preclinical Studies

A 1 hour online event, that includes a presentation followed by Q&A. This webinar will first define terminology in causal inference/data fusion and illustrate their use with two case studies.

PSI Medical Statistics Student Careers Event 2025

Date: 19 November 2025 This event is aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.

PSI Career Young Virtual Event (Q4 2025)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Panel discussion on ICH Q6b Specifications

Introduction to the topic, feedback from companies and open discussions. Brought to you by the CMC Statistical Network Europe (CSNE) SIG.

PSI Book Club Lunch and Learn: Communicating with Clarity and Confidence

If you have read Ros Atkins’ book The Art of Explanation or want to listen to the BBC’s ‘Communicator in Chief’, you are invited to join the PSI Book Club Lunch and Learn, to discuss the content and application with the author, Ros Atkins. Having written the book within the context of the news industry, Ros is keen to hear how we have applied the ideas as statisticians within drug development and clinical trials. There will be dedicated time during the webinar to ASK THE AUTHOR any questions – don’t miss out on this exclusive PSI Book Club event! Haven’t read the book yet? Pick up a copy today and join us. Explanation - identifying and communicating what we want to say - is described as an art, in the title of his book. However, the creativity comes from Ros’ discernment in identifying and describing a clear step-by-step process to follow and practice. Readers can learn Ros’ rules, developed and polished throughout his career as a journalist, to help communicate complex written or spoken information clearly.